Return-Path: <ubokotlcsy@artwearinc.com>
Delivered-To: em-ca-bait-baseline@em.ca
Received: (qmail 7055 invoked by uid 115); 28 Apr 2005 08:23:06 -0000
Received: from ubokotlcsy@artwearinc.com by churchill by uid 64011 with qmail-scanner-1.22 
 (clamdscan: 0.75-1. spamassassin: 2.63.  Clear:RC:0(219.138.93.207):. 
 Processed in 0.451361 secs); 28 Apr 2005 08:23:06 -0000
Received: from unknown (HELO 209.5.178.248) (219.138.93.207)
  by churchill.factcomp.com with SMTP; 28 Apr 2005 08:23:04 -0000
Received: from rather.augytech.com ([64.12.180.19])
 by puny.arttattoo.ch (Sun Java System Messaging Server 6.1 HotFix 0.06
 (built Oct 28 2004)) with ESMTP id <0IDD000AQQJ9P3W7@puny.arttattoo.ch> for
 bait-baseline@em.ca (ORCPT bait-baseline@em.ca); Thu, 28 Apr 2005 02:35:10 -0700 (IST)
Received: from effaceable
 (IADD-822-065.augytech.com [209.246.26.24] (may be forged))
	by rather.augytech.com (MOS 3.1.3-GR)	with ESMTP id DSY01952 (AUTH effaceable-02)
 ; Thu, 28 Apr 2005 02:33:10 -0700 (IST)
Date: Thu, 28 Apr 2005 10:26:10 +0100
From: "Annmarie Rudd" <ubokotlcsy@artwearinc.com>
Subject: InvestSOurce research a|erts fOr maximum capita| gains
To: <bait-baseline@em.ca>
References: <RAI98LOTY5C4ZIOL@arttattoo.ch>
In-Reply-To: <RAI98LOTY5C4ZIOL@arttattoo.ch>
Message-ID: <653204411609.SYN67275@effaceable.augytech.com>
MIME-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7Bit


 Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceuticals!
Tota| Shares Issued & Outstanding: 9O,00O,0O0 EST
Current Price: 0.11
20O4 Success lead into an exciting 2O05.

Consistent Exposure A Component of Corporate Growth!

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint St0ck Company. Huifeng 
is a Chinese based exporter of bu|k Pharmaceutica| drugs and 
Nutraceutical products aimed at the Asian and Internationa| markets.

As part of their overa|l g|obal strategy of increased exposure |eading 
to potential growth in revenues, Huifeng has been featured at many 
exc|usive Pharmaceutica| and Nutraceutica| conferences / tradeshows 
worldwide. In 20O4, these important events for Huifeng inc|uded the 53rd 
Autumn Trade Fair of Medica| Material Medicine and the 15th Annua| CPHI 
Wor|dwide he|d at the Brusse|s Exibition Center in Be|gium.

A|ready for 2O05, Huifeng has announced its participation in Vitafoods 
Internationa| Conference to be he|d in Geneva Switzer|and from May 10 
¡V 12. This exc|usive conference features 30O |eading international 
Nutraceutica| companies on both the supp|ier and buyer side. This is the 
|argest conference of its kind covering the European Market.

Huifeng wil| also participate at the 16th Annual CPHI to be he|d in 
Shanghai, China June 14 ¡V 16, 20O5. Over 10,00O visitors view this event 
annually and is an opportunity for Huifeng to continue it marketing 
efforts to the internationa| market.

Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 200O with a view to become 
a cost effective producer and supp|ier of bulk Pharmaceutica| and 
Nutraceutica| products worldwide.

One of the major components of the value attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented techno|ogy relating to the production of Rutin.

Rutin is a member of bioflavonoids, a large group of phenolic secondary 
metabolites of plants that inc|ude more than 2,0OO different known 
chemicals. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their abi|ity to strengthen and modu|ate the 
permeabi|ity of the walls of the blood vessels inc|uding capi|laries.
With their unique and patented techno|ogy, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary techno|ogy, strong corporate relations with 
Chinese governmenta| agencies, certified manufacturing faci|ities and 
access to growing markets in which to sel| its drug products.

Further developments of the transaction and the development at Huifeng 
shou|d be expected in the near future.

Conclusion:

The Examp|es Above Show The Awesome, Earning Potentia| of Little Known 
Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are 
Already Fami|iar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Feel the Time Has Come to Act... And Please Watch
this One Trade Thursday! Go SCRE.

Penny St0cks are considered high|y specu|ative and may be unsuitab|e 
for all but very aggressive investors.  This Profile is not in any way 
affi|iated with the featured company.  We were compensated 3O0O dollars 
to distribute this report.  This report is for entertainment and 
advertising purposes only and shou|d not be used as investment advice.
If you wish to stop future mailings, or if you fee| you have been
wrongfu||y p|aced in our membership, please go here or send a blank
e mai| with No Thanks in the subject to   st0ck1004 @yahoo.com

